Navigation Links
New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
Date:5/5/2008

100% of Insulin Doses Administered Were Delivered Within Pre-Determined

Guidelines and Standard Dosing Limitations

BRIDGEWATER, N.J., May 5 /PRNewswire-FirstCall/ -- A new study examining the dose accuracy of the SoloSTAR(R) disposable insulin pen, prefilled with Lantus(R) (insulin glargine [rDNA origin] injection) or Apidra(R) (insulin glulisine [rDNA origin] injection), found the pens accurately delivered all insulin doses within standard limits defined by the International Organization for Standardization (ISO). Lantus(R) SoloSTAR(R) was approved by the U.S. Food and Drug Administration (FDA) on April 25, 2007. Apidra(R) for use in the SoloSTAR(R) prefilled disposable pen is currently under review at the FDA. The study, presented on May 2, 2008 at the 43rd Congress of the German Society for Diabetes (DDG) in Munich, Germany, examined the accuracy of both pens at multiple target dosages to determine the proportion of doses that fell within ISO ranges.

"For people with diabetes who use an insulin pen to deliver their insulin, dose accuracy is essential for their treatment," stated Norbert Hermanns, Ph.D., director of the Research Institute of the Diabetes Academy Mergentheim, Bad Mergentheim, Germany, and lead investigator in the study. "Based on the findings of this study, we concluded that the SoloSTAR(R) pen is an accurate insulin delivery option for people with diabetes."

The study participants, a random sample of 60 hospital inpatients with type 1 and type 2 diabetes, were trained on correct use of the SoloSTAR(R) pen. Participants were then asked to inject three target doses with Lantus(R) into an insulin-sponge, in doses of 10 (low), 40 (medium) and 80 (high) units, and three doses of Apidra(R) in doses of 5 (low), 15 (medium) and 30 (high) units. The quantity of insulin delivered was calculated by the weight of the insulin pens before and after injection. The order of the dosages was randomized. All doses (100%)
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
4. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
5. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
6. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
7. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
8. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
9. Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
10. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
11. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...GO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc.(Nas...ngproductsforminimallydisruptivesurgicaltreatments...ecallonMonday,November30,2009,at5:30p.m.ET/2:30p.m...ivetoreimbursementfortheCompany,sproductsandwillin...nandanswersession.Thedial-innumbersare1-877-407-40...
(Date:11/25/2009)...GHAM,Mass.andSYDNEY,Nov.25/PRNewswire-FirstCall/--...,aleadinginnovatorandprovideroflessinvasive,miniat...gthetreatmentofadvancedheartfailure,todayannounced...21stAnnualPiperJaffrayHealthCareConferenceat8:00am...heldattheNewYorkPalaceHotel,December1-2. ,, Ali...
(Date:11/24/2009)...N,N.J.,Nov.24/PRNewswire-FirstCall/--QuestDiagnost...derofdiagnostictesting,informationandservices,anno...affrayHealthcareConferenceinNewYorkCity.Thepresent....m.EasternTime. ,, Duringtheconference,thecompa...roximate3%,operatingincometoexceed18%ofrevenues,an...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2New strategy for mending broken hearts 3F 10316 1New strategy for mending broken hearts 3F 10316 2Poor Education May Lead to Poor Health 59258 1Poor Education May Lead to Poor Health 59258 2Poor Education May Lead to Poor Health 59258 3Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 1Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 2Discrete Reportable Transcription to Populate the EHR EMR With Physician Dictated Reports 59255 3
...S, N.J., June 20, 2007 /PRNewswire-USNewswire/ -- ...the national,non-profit organization dedicated to...ries and improving the lives of people living,with...in President,Bush,s veto of the Stem Cell Research...or advancements in stem cell research with the,sup...
...alif.--(BUSINESS WIRE)--Jun 20, 2007 - Materia, In... the licensing of its,metathesis platform to Eisai...any, for use in drug discovery and development.,Th...to discover,develop, and patent pharmaceutical co...catalysts and associated intellectual property., M...
Other Medicine Technology:The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 2The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 3Materia Licenses Metathesis Catalyst Platform to Eisai 2
(Date:11/26/2009)... No more letters from the North Pole, Textsanta.n...ages from Santa , North P...ional efficiencies at the North Pole Santa Claus h...all over the globe informed of his Christmas progr...research department have identified a large and gr...
(Date:11/26/2009)... Ennis & Ennis, P.A. is offering free nationw...d Yasmin birth control pills who have suffered a D...oke, Heart Attack or other related cardiac issues ...oll free at 1-800-856-6405 or go to the firm&rsquo...ut an online case evaluation form. , ...
(Date:11/25/2009)...Y,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleadin...ndsoftwareandCalgaryScientificInc.,aleadingprovide...versionofAegis(TM)Breast4DAdvancedVisualizationsof...yzero-footprintWebclientbasedmedicalimagingofferin...mallowsforzero-footprintaccess-requiringnosoftware...
(Date:11/25/2009)...5/PRNewswire-USNewswire/--TheBlackAIDSInstituterec...iveleadershipfor2010. ,, ThenewBoardMembersarea...policy,law,finance,governmenthealthprograms,editor...romawiderangeofpersonalbackgroundsincludingbothhet...hemselves,andrepresentingmultipleagegroups. ,, ...
(Date:11/25/2009)... evidence of a statistically significant survival ...se estrogen receptor (ER)-positive tumors had high...118 (ER-alpha S118-P), according to a brief commun...al of the National Cancer Institute . , Approxim...moxifen. Preclinical studies have shown that ER-al...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
... that stents with certain drugs helps them do a be... vessels have been cleared surgically. But a new r...Researchers found that stents coated with a deriva...sulting in heart attacks in 3 cases. In angio...
...cells of oral leukoplakia, specifically the number...f oral carcinoma, according to study.// 123 patien...5 years, found that oral leukoplakia with the norm...ed cancer. However, if the number of chromoso...
... drug be injurious to health? Pharma giant GlaxoSm...essation drug, Zyban, has risen in defence of its ...eports in the UK, linking the drug to adverse reac...1. The cause for concern, however, was a safety up...
...chers, many people have believed that training wit...kept for youthful people.// According to Bruce Cra... University, men and women well past retirement ag...alls and injuries. The workouts will make you look...
...on of a tendon in the eye socket may help stop a m...n around the eye socket just before an attack star...lea tendon in the eye socket, a condition known as..., they studied five women with migraine who report...
...s, monounsaturated fats and carbohydrates can be i... offering more variety. Research done by Dr. Anura...s shown the benefits// of mono-unsaturated fats on...es experts now say that 50 to 60 per cent of calor...
Other Medicine News:
7.5mm Trephine Handle
1.0mm Trephine with Handle
8.5mm Calibrated Trephine Handle
9.0mm Calibrated Trephine Handle
Medicine Products: